Market Access/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis 5 years of biosimilars in the US: what have we learned? mike.hammerton@pharmaphorum.com biosimilars, Industry Pulse, US 0 Comment Biologics have created revolutionary treatment options that have transformed the care journey for hundreds of millions of patients Share X 5 years of biosimilars in the US: what have we learned? https://pharmaphorum.com/views-analysis-market-access/5-years-of-biosimilars-in-the-us-what-have-we-learned/
Views & Analysis/ Views and analysis Who could replace Sir Andrew Dillon at NICE? Richard Staines HTA, Industry Pulse, NICE, Sir Andrew Dillon 0 Comment With Sir Andrew Dillon announcing his retirement as chief executive of NICE, pharmaphorum discusses potential replacements for the Share X Who could replace Sir Andrew Dillon at NICE? https://pharmaphorum.com/views-and-analysis/who-could-replace-sir-andrew-dillon-at-nice/
